NYSE: NVO
Novo Nordisk A/S (NVO)
Company Profile
Exchange
NYSE: NVO
Headquarters
Bagsvaerd, Denmark
Founded
1923
Sector
Pharmaceuticals
Live Market Data
NVO Stock Chart
Company Overview
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes Care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas, including the Wegovy pill for weight management, smart insulin pens, and insulin dose guidance applications. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Novo Nordisk (NVO) News
Yahoo Finance
Novo Nordisk STEP Young Phase 3 Data: 40.4% of Children Living with Obesity Achieved a BMI Below the Obesity Threshold
Yahoo Finance
Highlights to Be Presented at Novo's Capital Markets Day 2026
GuruFocus
Novo Nordisk (NVO) Faces Stock Drop Amid New Growth Targets Announcement
GlobeNewswire
Novo Nordisk A/S Share Repurchase Programme Update
Yahoo Finance
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk
Access Top Brokerages
Free, No-Obligation Subscription